Genetically modified cells of haematopoietic and lymphocytic lineages could provide potentially curative treatments for a wide range of inherited and acquired diseases. However, this application is limited in mouse models by the low efficiency of lentiviral vectors. To facilitate the rapid production of high-titre helper-free retroviral vectors for enhanced gene delivery, multiple modifications to a prototype moloney murine leukemia virus (MoMLV)-derived vector system were made including adaptation of the vector system to simian virus 40 ori/T antigen-mediated episomal replication in packaging cells, replacement of the MoMLV 5′ U3 promoter with a series of stronger composite promoters and addition of an extra polyadenylation signal downstream of the 3′ long terminal repeat. These modifications enhanced vector production by 2–3 logs. High-titre vector stocks were tested for their ability to infect a variety of cells derived from humans and mice, including primary monocyte-derived macrophage cultures. Whilst the lentiviral vector was significantly restricted at the integration level, the MoMLV-based vector showed effective gene transduction of mouse cells. This high-titre retroviral vector system represents a useful tool for efficient gene delivery into human and mouse haematopoietic and lymphocytic cells, with particular application in mice as a small animal model for novel gene therapy tests.
AiutiA.,
CattaneoF.,
GalimbertiS.,
BenninghoffU.,
CassaniB.,
CallegaroL.,
ScaramuzzaS.,
AndolfiG.,
MiroloM.other authors2009; Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447–458
CampbellR. E.,
TourO.,
PalmerA. E.,
SteinbachP. A.,
BairdG. S.,
ZachariasD. A.,
TsienR. Y.2002; A monomeric red fluorescent protein. Proc Natl Acad Sci U S A 99:7877–7882
ClayT. M.,
CusterM. C.,
SpiessP. J.,
NishimuraM. I.1999; Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer. Pathol Oncol Res 5:3–15
CulverK.,
CornettaK.,
MorganR.,
MoreckiS.,
AebersoldP.,
KasidA.,
LotzeM.,
RosenbergS. A.,
AndersonW. F.,
BlaeseR. M.1991; Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci U S A 88:3155–3199
DonahueR. E.,
ByrneE. R.,
ThomasT. E.,
KirbyM. R.,
AgricolaB. A.,
SellersS. E.,
GaudernackG.,
KarissonS.,
LansdorpP. M.1996; Transplantation and gene transfer of the human glucocerebrosidase gene into immunoselected primate CD34+Thy-1+ cells. Blood 88:4166–4172
DouH.,
DestacheC. J.,
MoreheadJ. R.,
MosleyR. L.,
BoskaM. D.,
KingsleyJ.,
GorantlaS.,
PoluektovaL.,
NelsonJ. A.other authors2006; Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108:2827–2835
DouH.,
GrotepasC. B.,
McMillanJ. M.,
DestacheC. J.,
ChaubalM.,
WerlingJ.,
KippJ.,
RabinowB.,
GendelmanH. E.2009; Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183:661–669
MayT.,
ButuevaM.,
BantnerS.,
MarcusicD.,
SeppenJ.,
WeichH.,
HauserH.,
WirthD.2009; Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16:441–452
PearW. S.,
NolanG. P.,
ScottM. L.,
BaltimoreD.1993; Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90:8392–8396
QinX. F.,
AnD. S.,
ChenI. S.,
BaltimoreD.2003; Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100:183–188
RoszkowskiJ. J.,
LyonsG. E.,
KastW. M.,
YeeC.,
Van BesienK.,
NishimuraM. I.2005; Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Cancer Res 65:1570–1576
SchambachA.,
MuellerD.,
GallaM.,
VerstegenM. M. A.,
WagemakerG.,
LoewR.,
BaumC.,
BohneJ.2006; Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 13:1524–1533
SoneokaY.,
CannonP. M.,
RamsdaleE. E.,
GriffithsJ. C.,
RomanoG.,
KingsmanS. M.,
KingsmanA. J.1995; A transient three plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628–633